Eikon Therapeutics, Inc. · NASDAQ:EIKN

Innovation Endeavors III LP reported a 5.00% stake in Eikon Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Innovation Endeavors III LP reported a 5.00% stake in Eikon Therapeutics, Inc., 2,723,226 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
5.00%
Shares
2,723,226
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Innovation Endeavors III LP5.00%2,723,226
Innovation Endeavors III GP, LLC5.00%2,723,226
Innovation Endeavors IV LP0.90%498,474
Innovation Endeavors IV GP, LLC0.90%498,474
Innovation Endeavors ET SPV LP0.30%147,819
Innovation Endeavors ET SPV GP LLC0.30%147,819

Source

View original at SEC

Related